Literature DB >> 12604044

Interference of macrophages with immunotargeting of liposomes.

Gerben A Koning1, Jan A A M Kamps, Gerrit L Scherphof.   

Abstract

We investigated the binding, uptake and intracellular degradation of immunoliposomes by isolated rat liver macrophages in vitro. Immunoliposomes were prepared either by coupling a randomly thiolated anti-CC531 rat colon adenocarcinoma monoclonal antibody to bilayer-incorporated MPB-PE by means of a thioether linkage or by attaching it through its Fc moiety to the distal terminus of hydrazide-modified PEG-DSPE. The two immunoliposome preparations clearly differ in their interaction with the tumor target cells, as well as with the macrophages. At comparable antibody densities both cell types show 1.5-2-fold higher levels of association for the Hz-PEG-immunoliposomes than for the MPB-PEG-immunoliposomes. We provide evidence that immunoliposome macrophage-interaction is both Fc-receptor and scavenger receptor mediated to about equal extents. At low antibody density the hydrazide immunoliposomes favor interaction with the tumor cells to that with macrophages. At higher antibody densities, on the other hand, interaction of these liposomes with the macrophages is increasingly favored, mostly due to enhanced scavenger receptor mediated uptake. The rate of intracellular degradation of (immuno)liposomes internalized by liver macrophages is barely influenced by the presence of either PEG or immunoglobulins on the liposomal surface.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12604044     DOI: 10.1081/lpr-120004782

Source DB:  PubMed          Journal:  J Liposome Res        ISSN: 0898-2104            Impact factor:   3.648


  7 in total

1.  Development of target-specific liposomes for delivering small molecule drugs after reperfused myocardial infarction.

Authors:  Siva Sai Krishna Dasa; Ryo Suzuki; Michael Gutknecht; Lindsey T Brinton; Yikui Tian; Erik Michaelsson; Lennart Lindfors; Alexander L Klibanov; Brent A French; Kimberly A Kelly
Journal:  J Control Release       Date:  2015-06-27       Impact factor: 9.776

2.  Identification of Novel Ligands for Targeted Antifibrotic Therapy of Chronic Pancreatitis.

Authors:  Jessica Hung; Rohni Awasthi; Alexander L Klibanov; Kimberly A Kelly
Journal:  Int J Nanomedicine       Date:  2021-08-14

3.  Evaluation of pharmacokinetic and pharmacodynamic profiles of liposomes for the cell type-specific delivery of small molecule drugs.

Authors:  Siva Sai Krishna Dasa; Ryo Suzuki; Emily Mugler; Lanlin Chen; Rasmus Jansson-Löfmark; Erik Michaëlsson; Lennart Lindfors; Alexander L Klibanov; Brent A French; Kimberly A Kelly
Journal:  Nanomedicine       Date:  2017-07-25       Impact factor: 5.307

4.  Targeted liposomal drug delivery to monocytes and macrophages.

Authors:  Ciara Kelly; Caroline Jefferies; Sally-Ann Cryan
Journal:  J Drug Deliv       Date:  2010-10-26

5.  Advancement and applications of peptide phage display technology in biomedical science.

Authors:  Chien-Hsun Wu; I-Ju Liu; Ruei-Min Lu; Han-Chung Wu
Journal:  J Biomed Sci       Date:  2016-01-19       Impact factor: 8.410

6.  Hepatocellular carcinoma-targeted nanoparticles for cancer therapy.

Authors:  Chien-Hsun Wu; Chun-Hsin Lan; Kuan-Lin Wu; Yao-Ming Wu; Wann-Neng Jane; Michael Hsiao; Han-Chung Wu
Journal:  Int J Oncol       Date:  2017-11-16       Impact factor: 5.650

Review 7.  Immunotoxicity Considerations for Next Generation Cancer Nanomedicines.

Authors:  Gary Hannon; Joanne Lysaght; Neill J Liptrott; Adriele Prina-Mello
Journal:  Adv Sci (Weinh)       Date:  2019-08-01       Impact factor: 16.806

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.